Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1705800 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL2871946 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL3078400 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1114864 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1076957 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL2869472 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL1395419 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL10980289 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 | |
| SCHEMBL298912 | 1.00 | — | — | |
| SCHEMBL2859340 | 1.00 | TSHR (0.62) | TSHRALDH1A1THRBFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024123720-A1 | COATED ARTICLES WITH AN ANTI-FINGERPRINT COATING OR SURFACE-MODIFYING LAYER AND METHODS OF MAKING THE SAME | CORNING INCORPORATED (US) | 2024-06-13 | — | — | WO | claimed |
| US-20230182110-A1 | METHOD AND MATERIALS FOR EXTRACTION OF OIL-SOLUBLE ORGANIC MOLECULAR TRACERS FROM OIL PHASES | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-15 | — | — | US | claimed |
| US-20200352900-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS | MEDERIS DIABETES LLC (US) | 2020-11-12 | — | — | US | claimed |
| EP-3735295-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS | Mederis Diabetes, LLC (US) | 2020-11-11 | — | — | EP | claimed |
| WO-2019136158-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS | SPITFIRE PHARMA, INC. (US) | 2019-07-11 | — | — | WO | claimed |
| CN-106661097-A | Improved peptide drugs against insulin resistance | 梅德瑞斯糖尿病有限责任公司 | 2017-05-10 | — | — | CN | claimed |
| EP-3155017-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | Mederis Diabetes, LLC (US) | 2017-04-19 | — | — | EP | claimed |
| US-20170096468-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | HERCULES CAPITAL, INC., AS AGENT | 2017-04-06 | — | — | US | claimed |
| EP-2376221-B1 | MODIFIED CLAY SORBENTS | CRC CARE PTY LTD (AU) | 2017-03-15 | — | — | EP | claimed |
| CN-105646777-A | Hydrophobic associated polymer and preparation method thereof | 四川光亚聚合物化工有限公司 | 2016-06-08 | — | — | CN | claimed |
| EP-2376221-A1 | MODIFIED CLAY SORBENTS | CRC Care Pty Ltd (AU) | 2011-10-19 | — | — | EP | claimed |
| CN-102138869-A | Peptide-based conditioner and colorant for hair, skin and nail | DU PONT | 2011-08-03 | — | — | CN | claimed |
| CN-1863501-B | Peptide-based conditioners and colorants for hair, skin and nails | DU PONT | 2011-05-25 | — | — | CN | claimed |
| WO-2010065996-A1 | MODIFIED CLAY SORBENTS | CRC CARE PTY LTD (AU) | 2010-06-17 | — | — | WO | claimed |
| CN-101453981-A | Peptide-based body surface coloring reagents | DU PONT (US) | 2009-06-10 | — | — | CN | claimed |
| CN-1296397-C | Antibacterial high water-absorbent resin and method for preparation thereof | ZHONGKAI AGROTECHNICAL COLLEGE (CN) | 2007-01-24 | — | — | CN | claimed |
| CN-1863501-A | Peptide-based conditioners and colorants for hair, skin and nails | DU PONT (US) | 2006-11-15 | — | — | CN | claimed |
| CN-1670047-A | Antibacterial high water-absorbent resin and method for preparation thereof | ZHONGKAI AGROTECHNICAL COLLEGE (CN) | 2005-09-21 | — | — | CN | claimed |
| US-4726945-A | MIXTURE OF QUATERNARY AMMONIUM COMPOUND, ALKYLAMIDODIALKYLAMINE, PROPYLENE GLYCOL, MINERAL OIL, FATTY ALCOHOL AND SILOXANE | COLGATE-PALMOLIVE CO. (US) | 1988-02-23 | — | — | US | claimed |
| US-3951857-A | TRIS(ALKYL)PHOSPHORIC TRIAMIDE | TEXACO INC. (US) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170096468-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE | IAPP, PTMS, GLP1R | TSHR 268/4885ALDH1A1 4702/4885THRB 317/4885 |
| US-20200352900-A1 | IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS | IAPP, GLP1R, FABP4 | TSHR 767/4885ALDH1A1 4659/4885THRB 1200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.